Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.


Journal

Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395

Informations de publication

Date de publication:
2020
Historique:
received: 17 02 2020
accepted: 22 03 2020
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 27 7 2021
Statut: epublish

Résumé

Two important features are required for promising radiosensitizers: one is selective tumor cell targeting to enhance the therapeutic outcome via lethal DNA damage and the other is rapid clearance to enable excellent biocompatibility for potential clinical application. Herein, ultrasmall gold nanoparticles (Au NPs) with diameter smaller than 5 nm were prepared and covered with a multifunctional peptide to endow them with selective tumor cell uptake capability. Combined with X-ray irradiation, the responsive Au NPs demonstrated superior radio-sensitizing toxicity and rapid renal clearance

Identifiants

pubmed: 32373207
doi: 10.7150/thno.45017
pii: thnov10p5195
pmc: PMC7196283
doi:

Substances chimiques

Reactive Oxygen Species 0
Gold 7440-57-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5195-5208

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Acc Chem Res. 2018 Nov 20;51(11):2848-2856
pubmed: 30346728
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6656-61
pubmed: 21464325
Biomaterials. 2018 Oct;180:193-205
pubmed: 30048909
ACS Nano. 2013 Apr 23;7(4):3388-402
pubmed: 23530622
Small. 2019 Nov;15(47):e1903254
pubmed: 31549785
Chem Soc Rev. 2018 Jul 30;47(15):5554-5573
pubmed: 29856446
J Am Chem Soc. 2017 Jun 28;139(25):8547-8551
pubmed: 28598151
Small. 2019 Aug;15(34):e1900968
pubmed: 31265213
Sci Rep. 2015 Mar 02;5:8669
pubmed: 25727895
Adv Mater. 2019 Jan;31(3):e1802244
pubmed: 30156333
Nature. 2012 Jan 18;481(7381):287-94
pubmed: 22258607
Adv Mater. 2018 May;30(22):e1703444
pubmed: 29460400
Adv Mater. 2017 Aug;29(32):
pubmed: 28643452
Adv Mater. 2014 Jul 9;26(26):4565-8
pubmed: 24817169
Angew Chem Int Ed Engl. 2018 Jul 9;57(28):8463-8467
pubmed: 29757483
Nat Commun. 2018 Feb 22;9(1):766
pubmed: 29472567
Adv Funct Mater. 2017 Sep 13;27(34):
pubmed: 29151826
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4164-9
pubmed: 27035960
Nat Commun. 2018 Oct 18;9(1):4335
pubmed: 30337535
Phys Med Biol. 2004 Sep 21;49(18):N309-15
pubmed: 15509078
Adv Mater. 2015 Oct 28;27(40):6110-7
pubmed: 26331476
Science. 2016 Feb 19;351(6275):841-5
pubmed: 26912892
ACS Nano. 2018 Jan 23;12(1):7-12
pubmed: 29283247
Adv Mater. 2016 Jul;28(28):5923-30
pubmed: 27165472
Acc Chem Res. 2013 Mar 19;46(3):761-9
pubmed: 23964655
ACS Nano. 2014 Jan 28;8(1):104-12
pubmed: 24377302
Nat Commun. 2018 Jun 15;9(1):2351
pubmed: 29907739
Adv Mater. 2017 Apr;29(14):
pubmed: 28234430
Adv Mater. 2019 Mar;31(10):e1802228
pubmed: 30663118
Nanomedicine. 2015 Nov;11(8):2083-98
pubmed: 26115635
Angew Chem Int Ed Engl. 2015 Feb 2;54(6):1780-6
pubmed: 25504495
Biomaterials. 2015 Jul;56:58-67
pubmed: 25934279
ACS Nano. 2016 Feb 23;10(2):2536-48
pubmed: 26815933
Adv Mater. 2016 Oct;28(39):8567-8585
pubmed: 27461909
J Am Chem Soc. 2013 Apr 3;135(13):5068-73
pubmed: 23464924
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4311-6
pubmed: 20160077
Theranostics. 2019 Jul 9;9(18):5214-5226
pubmed: 31410211
Adv Sci (Weinh). 2019 Jan 08;6(8):1801806
pubmed: 31016110
Acta Biomater. 2019 Mar 1;86:363-372
pubmed: 30660006
Acta Biomater. 2017 Mar 1;50:534-545
pubmed: 28027959
Adv Mater. 2019 Nov;31(46):e1901015
pubmed: 31576632
Sci Transl Med. 2014 Oct 29;6(260):260ra149
pubmed: 25355699
Nat Biomed Eng. 2018 Nov;2(11):865-877
pubmed: 30505626
Nanomedicine (Lond). 2013 Oct;8(10):1601-9
pubmed: 23265347
Adv Healthc Mater. 2014 Jan;3(1):133-41
pubmed: 23873780
Theranostics. 2018 Feb 12;8(7):1824-1849
pubmed: 29556359
Adv Mater. 2016 Jul;28(25):5072-9
pubmed: 27136070
Biomaterials. 2020 Jan;226:119538
pubmed: 31639541
Nanoscale. 2018 May 31;10(21):10166-10172
pubmed: 29786738
Biomaterials. 2020 Feb;232:119677
pubmed: 31865193
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17047-52
pubmed: 24062440
Transl Cancer Res. 2013 Aug;2(4):
pubmed: 24392307
Adv Mater. 2020 Feb;32(6):e1906024
pubmed: 31834662
Biomaterials. 2009 Oct;30(29):5892-6
pubmed: 19631374
Nat Rev Clin Oncol. 2013 Jan;10(1):52-60
pubmed: 23183635

Auteurs

Yuan Ding (Y)

Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang.
Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.

Zhongquan Sun (Z)

Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang.
Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.

Zongrui Tong (Z)

MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.

Sitong Zhang (S)

Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang.
Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.

Jie Min (J)

Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang.
Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Department of Hepatobiliary and Pancreatic Surgery, the First Hospital of Jiaxing, Jiaxing, Zhejiang 330440.

Qianhui Xu (Q)

Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang.
Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.

Liuzhi Zhou (L)

Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang.
Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.

Zhengwei Mao (Z)

MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.

Haibing Xia (H)

State Key Laboratory of Crystal Materials, Shandong University, Jinan 250100.

Weilin Wang (W)

Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009.
Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang 310009.
Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang 310009.
Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, Zhejiang.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH